Careers
Contact

About
Science & Approach
Pipeline
News & Progress
Careers
Contact

HYDRA Platform Development to Investigate Siglec-engaging Tumor Immunosuppressive Glyco-codes

Press Release

HYDRA Platform Development to Investigate Siglec-engaging Tumor Immunosuppressive Glyco-codes

© 2021, PALLEON PHARMACEUTICALS

Palleon and the Palleon logo are registered trademarks of Palleon Pharmaceuticals.